Thermo Fisher Scientific Inc
NYSE:TMO
Thermo Fisher Scientific Inc
Income from Continuing Operations
Thermo Fisher Scientific Inc
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Income from Continuing Operations
$6B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
15%
|
CAGR 10-Years
17%
|
|
Danaher Corp
NYSE:DHR
|
Income from Continuing Operations
$7.5B
|
CAGR 3-Years
17%
|
CAGR 5-Years
28%
|
CAGR 10-Years
12%
|
|
West Pharmaceutical Services Inc
NYSE:WST
|
Income from Continuing Operations
$552.4m
|
CAGR 3-Years
11%
|
CAGR 5-Years
21%
|
CAGR 10-Years
18%
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Income from Continuing Operations
$777.8m
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
10%
|
|
Agilent Technologies Inc
NYSE:A
|
Income from Continuing Operations
$1.2B
|
CAGR 3-Years
15%
|
CAGR 5-Years
1%
|
CAGR 10-Years
22%
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Income from Continuing Operations
$1.4B
|
CAGR 3-Years
65%
|
CAGR 5-Years
42%
|
CAGR 10-Years
20%
|
See Also
What is Thermo Fisher Scientific Inc's Income from Continuing Operations?
Income from Continuing Operations
6B
USD
Based on the financial report for Dec 31, 2023, Thermo Fisher Scientific Inc's Income from Continuing Operations amounts to 6B USD.
What is Thermo Fisher Scientific Inc's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 10Y
17%
Over the last year, the Income from Continuing Operations growth was -16%. The average annual Income from Continuing Operations growth rates for Thermo Fisher Scientific Inc have been -2% over the past three years , 15% over the past five years , and 17% over the past ten years .